Immediate Effects on Gait and Spasticity After the Use of Passive Kinesiotherapy Equipment in the Lower Limbs of Neurological Patients
Launched by FERNANDA TRUBIAN · Nov 16, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • agree and sign the Free and Informed Consent Form or signature of the person responsible
- • individuals with spasiticity (hemiparetic, paraparetic, tetraparetic and hemiparetic children with cerebral palsy)
- Exclusion Criteria:
- • over 18 years old whose ability to sign the Free and Informed Consent Form is compromised, or who understand it, but are not responsible for signing the Free and Informed Consent Form
- • present cardiovascular, neurological, musculoskeletal instability or other condition(s) that interfere with the use or positioning of the device or gait assessment
- • present cognitive deficits that interfere with understanding the ICF and/or understanding how to carry out the protocol
- • For the children's group, participants who: 1) are under 8 years of age and/or over 13 years of age will be excluded; 2) no person responsible for signing the TCLE; 3) present cognitive deficits that interfere with understanding the ICF and/or understanding how to carry out the protocol
About Fernanda Trubian
Fernanda Trubian is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative studies. With a commitment to ethical practices and rigorous methodologies, the organization aims to facilitate the development of new therapies across various therapeutic areas. By fostering collaboration among researchers, healthcare professionals, and regulatory bodies, Fernanda Trubian seeks to accelerate the translation of scientific discoveries into effective treatments, ensuring that patient safety and well-being remain at the forefront of all clinical endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Caxias Do Suk, Rio Grande Do Sul, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported